10 articles for thisTarget

---

The following articles (labelled with PubMed ID or TBD) are for your review

PMID	Data	Article Title	Organization
26318054	48	4-Aminoquinoline derivatives as novel Mycobacterium tuberculosis GyrB inhibitors: Structural optimization, synthesis and biological evaluation.	Birla Institute Of Technology
25129171	29	Design, synthesis, biological evaluation of substituted benzofurans as DNA gyraseB inhibitors of Mycobacterium tuberculosis.	Institute Of Technology & Science-Pilani
25801151	50	Design and synthesis of novel quinoline-aminopiperidine hybrid analogues as Mycobacterium tuberculosis DNA gyraseB inhibitors.	Birla Institute Of Technology
25766629	30	Development of 2-amino-5-phenylthiophene-3-carboxamide derivatives as novel inhibitors of Mycobacterium tuberculosis DNA GyrB domain.	Birla Institute Of Technology
25050172	32	Benzimidazoles: novel mycobacterial gyrase inhibitors from scaffold morphing.	Astrazeneca
25456076	29	An efficient synthesis and biological screening of benzofuran and benzo[d]isothiazole derivatives for Mycobacterium tuberculosis DNA GyrB inhibition.	TBA
24809953	28	Novel N-linked aminopiperidine-based gyrase inhibitors with improved hERG and in vivo efficacy against Mycobacterium tuberculosis.	Astrazeneca
24088190	38	Thiazolopyridine ureas as novel antitubercular agents acting through inhibition of DNA Gyrase B.	Astrazeneca India
24405701	30	Thiazolopyridone ureas as DNA gyrase B inhibitors: optimization of antitubercular activity and efficacy.	Astrazeneca
24148991	5	Thiazole-aminopiperidine hybrid analogues: design and synthesis of novel Mycobacterium tuberculosis GyrB inhibitors.	Birla Institute Of Technology